Escape from autologous humoral immunity of HIV-1 is not associated with a decrease in replicative capacity

被引:15
作者
Bunnik, Evelien M.
Lobbrecht, Marilie S. D.
van Nuenen, Ad C.
Schuitemaker, Hanneke [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands
关键词
HIV-1; NAb escape; Envelope; Replication rate; IMMUNODEFICIENCY-VIRUS TYPE-1; NEUTRALIZING ANTIBODY-RESPONSE; CORECEPTOR USAGE; RANTES SENSITIVITY; VARIANTS; ENVELOPE; INFECTION; REVERSION; EVOLUTION; SELECTION;
D O I
10.1016/j.virol.2009.11.009
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Autologous HIV-1-specific neutralizing antibodies (NAbs) seem unable to inhibit viral replication as they rapidly select for neutralization escape variants. However, NAbs could potentially contribute indirectly to the control of HIV-1 if changes in the viral envelope coinciding with NAb escape would impair viral replication fitness. Here we analyzed the replication kinetics of HIV-1 isolated over the course of infection from five typical progressors, three of whom developed strong autologous neutralizing humoral immunity. Viral replication rate did not correlate with viral sensitivity to autologous serum neutralization or with envelope length or number of potential N-linked glycosylation sites in gp120, suggesting that the flexibility of the viral envelope allows escape from NAbs without the loss of viral fitness. Interestingly, the appearance of rapidly replicating viruses late in infection correlated with lower CD4(+) T-cell counts, suggesting that this viral characteristic may be positively selected when the availability of target cells becomes limiting. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:224 / 230
页数:7
相关论文
共 52 条
[1]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[2]  
ARENDRUP M, 1992, J ACQ IMMUN DEF SYND, V5, P303
[3]   Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations [J].
Bailey, Justin R. ;
Williams, Thomas M. ;
Siliciano, Robert F. ;
Blankson, Joel N. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (05) :1357-1369
[4]   Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course [J].
Beaumont, T ;
van Nuenen, A ;
Broersen, S ;
Blattner, WA ;
Lukashov, VV ;
Schuitemaker, H .
JOURNAL OF VIROLOGY, 2001, 75 (05) :2246-2252
[5]   RAPID AND SIMPLE METHOD FOR PURIFICATION OF NUCLEIC-ACIDS [J].
BOOM, R ;
SOL, CJA ;
SALIMANS, MMM ;
JANSEN, CL ;
WERTHEIMVANDILLEN, PME ;
VANDERNOORDAA, J .
JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (03) :495-503
[6]   Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy [J].
Brumme, ZL ;
Dong, WWY ;
Yip, B ;
Wynhoven, B ;
Hoffman, NG ;
Swanstrom, R ;
Jensen, MA ;
Mullins, JI ;
Hogg, RS ;
Montaner, JSG ;
Harrigan, PR .
AIDS, 2004, 18 (04) :F1-F9
[7]   Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection [J].
Bunnik, Evelien M. ;
Pisas, Linaida ;
van Nuenen, Ad C. ;
Schuitemaker, Hanneke .
JOURNAL OF VIROLOGY, 2008, 82 (16) :7932-7941
[8]   VIROLOGICAL AND IMMUNOLOGICAL CHARACTERIZATION OF LONG-TERM SURVIVORS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
CAO, YZ ;
QIN, LM ;
ZHANG, LQ ;
SAFRIT, J ;
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (04) :201-208
[9]   A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects [J].
Cecilia, D ;
Kleeberger, C ;
Muñoz, A ;
Giorgi, JV ;
Zolla-Pazner, S .
JOURNAL OF INFECTIOUS DISEASES, 1999, 179 (06) :1365-1374
[10]   Selection for human immunodeficiency virus type I envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels [J].
Chohan, B ;
Lang, D ;
Sagar, M ;
Korber, B ;
Lavreys, L ;
Richardson, B ;
Overbaugh, J .
JOURNAL OF VIROLOGY, 2005, 79 (10) :6528-6531